The purpose of this contract is to evaluate and modulate the molecular pathways involved in regulating and enhancing HIV envelope/antigen expression in mammalian cell lines and to accelerate development of purification platforms in a cGMP manufacturing se

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 272201800017C-0-0-0
Agency Tracking Number: N43AI180017
Amount: $599,997.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: NIAID
Solicitation Number: N/A
Timeline
Solicitation Year: 2017
Award Year: 2018
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
650 ALBANY STREET UNIT 112, Boston, MA, 02118-2518
DUNS: 828948658
HUBZone Owned: Y
Woman Owned: N
Socially and Economically Disadvantaged: Y
Principal Investigator
 Wenda GAO
 (617) 638-0315
 WENDAGAO01@GMAIL.COM
Business Contact
 Wenda GAO
Phone: (617) 638-0315
Email: WENDAGAO01@GMAIL.COM
Research Institution
N/A
Abstract
HIVthe virus that causes AIDSis one of the world s most serious health and development challengesAccording to UNAIDSthere were approximatelymillion people worldwide living with HIV AIDS at the end ofThe vast majority of people living with HIV are in lowto middle income countriesparticularly in sub Saharan AfricaA low cost vaccine is the preferred response to protect the human populationHoweverdespite tremendous effortsno effective vaccine has been foundThis is due largely to specific features of the HIVenvelope glycoproteinEnvwhich is uniquely exposed on the surface of the virionIn this SBIRwe aim to use glyco engineered CHO cell line to express stabilized Env trimermimicking the native structure on HIV virionMoreoverwe will engineer the Env to be fused with antibody fragment to enhance the interaction with the host immune systemOne of the key elements for the success of HIV vaccine is the cost effectivenessVaccine developers should make great efforts to reduce the manufacture cost in order to have a larger penetration of the vaccine in the risk populationWith our new approaches and advanced CHO cell expression platformwe are one step closer to achieve this goal

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government